RightFit
RecruitingPhase not listed

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
No age limits stated
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study looks at how people with glaucoma respond to Xiidra for discomfort on the eye's surface. It is for people using glaucoma eye drops who are prescribed Xiidra as part of their usual care.

To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Currently use one or more glaucoma eye drops to lower eye pressure.
  • Report discomfort on the surface of your eyes.
  • Are being prescribed Xiidra as part of your usual care.

Who can't join

  • Have had glaucoma filtration surgery, which helps fluid drain from the eye.
  • Have had surgery on the surface of your eye.
  • Currently use cyclosporine eye medicine.
  • Currently use steroid eye medicine.
  • Have had eye surgery involving a cut within the past 6 months.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Currently using one or more topical glaucoma antihypertensives * Self-described symptoms of ocular surface discomfort * Xiidra is being prescribed as part of the subject's standard care Exclusion Criteria: * History of glaucoma filtration surgery, history of ocular surface surgery (pterygium, conjunctivoplasty, etc.), * current use of topical cyclosporine * current use of topical steroids * incisional ocular surgery within 6 months

Study sites (1)

CA